SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001683168-19-003967
Filing Date
2019-12-13
Accepted
2019-12-13 16:30:10
Documents
3
Effectiveness Date
2019-12-13

Document Format Files

Seq Description Document Type Size
1 ADDITIONAL PROXY MATERIALS phio_defa.htm DEFA14A 23194
2 GRAPHIC image_001.jpg GRAPHIC 2492
3 GRAPHIC image_001.gif GRAPHIC 2399
  Complete submission text file 0001683168-19-003967.txt   31198
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36304 | Film No.: 191284908
SIC: 2834 Pharmaceutical Preparations